Doxorubicin was conjugated with the PEPT1 substrate Gly-Gly-Gly, followed by the investigation of the anti-tumor effect of Doxorubicin-tripeptide conjugate in liver cancer cells and xenografts. This evidence concerns the gene SLC15A1 and liver cancer.